GlassScriptPhysician profile
Stephanie Whitbey
NPI 1043796444
$12,013.64
in general payments reported to CMS, 2019-2025
40 companies · $2,504 in 2025
The $2,504 reported for 2025 was more than what 98% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
See the full distribution for Critical Care Medicine (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,992 · 2022: $2,519 · 2023: $2,561 · 2024: $2,438 · 2025: $2,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,440 · Education: $62.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,439.62 |
| Education | $62.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,714.16 | 2021-2025 | Breztri, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,306.76 | 2021-2025 | Ofev, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $1,170.73 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $1,108.94 | 2021-2025 | Nucala, Arexvy |
| Genzyme Corporation | $1,096.80 | 2021-2025 | |
| Grifols USA, LLC | $502.12 | 2021-2025 | Prolastin-C Liquid, Xembify |
| Electromed, INC. | $425.79 | 2021-2025 | Smartvest |
| Genentech USA, INC. | $380.75 | 2022-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $372.70 | 2022-2025 | Glassia |
| Mylan Specialty L.P. | $365.01 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $327.21 | 2022-2025 | Tyvaso, Tyvaso |
| Jazz Pharmaceuticals INC. | $291.39 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $206.03 | 2022-2025 | Acthar |
| Viatris Specialty LLC | $198.60 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $187.40 | 2023-2024 | Inspire |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $139.78 | 2021-2025 | Tezspire |
| Philips North America LLC | $120.54 | 2021-2024 | (8874) Incourage |
| Insmed, INC. | $110.13 | 2023-2025 | Arikayce |
| Gilead Sciences, INC. | $103.39 | 2021-2022 | |
| Baxter Healthcare | $101.14 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $91.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.71 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $71.27 | 2021-2025 | Capvaxive, Keytruda |
| Sanofi-Aventis U.S. LLC | $59.80 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $57.85 | 2021-2025 | Opsynvi, Uptravi |
| Resmed Corp | $50.08 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $46.46 | 2021 | |
| Ambu INC. | $44.72 | 2023 | |
| Verona Pharma, INC. | $36.75 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $34.65 | 2021-2022 | |
| Advanced Respiratory, INC | $32.38 | 2021 | |
| Pulmonx Corporation | $31.40 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Biomerieux INC | $29.44 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $18.80 | 2022 | |
| Tactile Systems Technology INC | $18.72 | 2025 | Nimbl, Flexitouch Plus |
| Hill-Rom Company, INC | $18.42 | 2021 | |
| La Jolla Pharmaceutical Company | $16.65 | 2021 | |
| Phadia US INC. | $13.75 | 2025 | Immunocap |
| Paratek Pharmaceuticals, INC. | $12.37 | 2022 | |
| Breas Medical, INC. | $12.06 | 2025 | Vivo 1/2, Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Whitbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.